Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.